| Missouri | Prior-authorization path for weight management | MO HealthNet PDL edit, GLP-1 Receptor Agonists Indicated for Obesity (revised April 23, 2026) | Nov 15, 2026 |
| North Carolina | Prior-authorization path for weight management | NC Medicaid bulletin, December 19, 2025 | Nov 15, 2026 |
| Tennessee | Prior-authorization path for weight management | TennCare prior authorization form, Weight Management Agents (revised 08/2026), on OptumRx's TennCare site | Nov 15, 2026 |
| Virginia | Prior-authorization path for weight management | DMAS service authorization form, Weight-Loss Management (effective 07/01/2026), hosted on the Virginia Medicaid Pharmacy Services portal | Nov 15, 2026 |
| Wisconsin | Prior-authorization path for weight management | ForwardHealth Update No. 2026-15, June 2026 | Nov 15, 2026 |
| Michigan | Covered for obesity, with added limits | MDHHS letter L 25-73, December 8, 2025 | Nov 15, 2026 |
| Alabama | Not covered for weight loss alone | Alabama Medicaid PDL Reference Tool, effective 07/01/2026 | Nov 15, 2026 |
| Arizona | Not covered for weight loss alone | AHCCCS Fee-For-Service Provider Manual, Chapter 12 (Pharmacy) | Nov 15, 2026 |
| California | Not covered for weight loss alone | Medi-Cal Rx alert, October 21, 2025 | Nov 15, 2026 |
| Colorado | Not covered for weight loss alone | HCPF Pharmacy Billing Manual, Restricted Products | Nov 15, 2026 |
| Florida | Not covered for weight loss alone | AHCA Prescribed Drug Services Coverage Policy (December 2017) | Nov 15, 2026 |
| Illinois | Not covered for weight loss alone | Illinois Medicaid Preferred Drug List, effective October 20, 2026 | Nov 15, 2026 |
| Indiana | Not covered for weight loss alone | Indiana Medicaid for Members: Pharmacy Benefits | Nov 15, 2026 |
| Iowa | Not covered for weight loss alone | Iowa Administrative Code 441-78.2(249A), Prescribed outpatient drugs (version effective 7/1/26) | Nov 15, 2026 |
| Kentucky | Not covered for weight loss alone | Kentucky Medicaid pharmacy notice (MedImpact), GLP-1 prior authorization criteria changes, September 2, 2025 | Nov 15, 2026 |
| Louisiana | Not covered for weight loss alone | Louisiana Medicaid Provider Manual, Chapter 37 Pharmacy, Section 37.1 (issued 03/30/26) | Nov 15, 2026 |
| Maryland | Not covered for weight loss alone | Transmittal PT 35-25, September 13, 2024 | Nov 15, 2026 |
| Nevada | Not covered for weight loss alone | Nevada Medicaid Services Manual, Chapter 1200 Prescribed Drugs (effective August 31, 2026) | Nov 15, 2026 |
| New Jersey | Not covered for weight loss alone | NJ Department of Human Services memo to the Legislature (SFY 2026) | Nov 15, 2026 |
| New Mexico | Not covered for weight loss alone | New Mexico Health Care Authority web page, Weight Reduction Medications | Nov 15, 2026 |
| Oregon | Not covered for weight loss alone | Oregon Medicaid Pharmaceutical Services Prior Authorization Criteria, July 1, 2026 | Nov 15, 2026 |
| Pennsylvania | Not covered for weight loss alone | Medical Assistance Bulletin, November 24, 2025 | Nov 15, 2026 |
| Rhode Island | Not covered for weight loss alone | EOHHS memo, August 5, 2026 | Nov 15, 2026 |
| Utah | Not covered for weight loss alone | Utah Medicaid Information Bulletin, May 2026 (item 26-45) | Nov 15, 2026 |
| Vermont | Not covered for weight loss alone | DVHA Preferred Drug List, updated 10/02/2026 | Nov 15, 2026 |
| Washington | Not covered for weight loss alone | HCA medical policy 61.25.20.AA-4, effective 2/1/2026 | Nov 15, 2026 |
| West Virginia | Not covered for weight loss alone | BMS prior authorization criteria, Zepbound (effective 7/1/2025) | Nov 15, 2026 |
| Connecticut | Criteria listed only for non-obesity uses | HUSKY Therapeutic Class ICD-10 Diagnosis List, updated 9/25/2026 | Nov 15, 2026 |
| Massachusetts | Criteria listed only for non-obesity uses | MassHealth Drug List, Table 72: Agents Not Otherwise Classified | Nov 15, 2026 |
| Nebraska | Criteria listed only for non-obesity uses | Nebraska Medicaid Anti-Obesity Medication PA Form, Wegovy | Nov 15, 2026 |
| New York | Criteria listed only for non-obesity uses | NYRx Preferred Drug Program list | Nov 15, 2026 |
| Ohio | Criteria listed only for non-obesity uses | Ohio Medicaid Unified Preferred Drug List, effective April 1, 2026 | Nov 15, 2026 |
| Oklahoma | Criteria listed only for non-obesity uses | Oklahoma Health Care Authority prior authorization criteria, Metabolic Disorders (last modified Oct 1, 2026) | Nov 15, 2026 |